Available Structures

13 Experimental Structures

DescriptionOligo-stateLigandsStructureRange
Crystal Structure of HIV Protease complexed with methyl N-[(1S)-1-benzhydryl-2-[2-[2-[(2R,5S)-5-(be…homo-2-merCL;6EF;1-99
Assess
Crystal Structure of HIV Protease complexed with methyl N-[(1S)-1-[[2-[(3S)-3-[(4-aminophenyl)methy…homo-2-merCL;6EG;1-99
Assess
X-ray crystal structure of wild type HIV-1 protease in complex with GRL-063homo-2-merEDO;MJD;1-99
Assess
Crystal Structure of HIV Protease complexed with methyl N-[(1S)-1-benzhydryl-2-(3-morpholin-4-ium-2…homo-2-mer6EH;CL;1-99
Assess
Inhibitor of HIV protease with unusual binding mode potently inhibiting multi-resistant protease mu…homo-2-merQ50;1-99
Assess
Crystal structure of HIV-1 Protease NL4-3 I50V Mutant in complex with UMass6homo-2-merSO4;A60;1-99
Assess
Crystal structure of HIV-1 Protease NL4-3 WT in complex with UMass1homo-2-merSO4;K13;1-99
Assess
Crystal structure of HIV-1 Protease NL4-3 I50V Mutant in complex with darunavirhomo-2-merSO4;017;1-99
Assess
Crystal structure of HIV-1 Protease NL4-3 WT in complex with UMass6homo-2-merSO4;A60;1-99
Assess
Crystal structure of HIV-1 Protease NL4-3 I50V Mutant in complex with UMass1homo-2-merSO4;K13;1-99
Assess
HIV-1 Protease NL4-3 WT in complex with darunavirhomo-2-mer017;1-99
Assess
HIV Protease (PR) dimer in closed form with pepstatin in active site and fragment AK-2097 in the ou…homo-2-merK97;GOL;1-99
Assess
HIV Protease (PR) dimer in closed form with TL-3 in active site and fragment AK-2097 in the outside…homo-2-mer3TL;BME;K97;1-99
Assess

1 Homology model

Oligo-stateLigandsQMEANDisCoTemplateRangeSeq id (%)
homo-2-mer0.841z8c.1.A1-99
94.95
Assess

Alignments